| Literature DB >> 33635633 |
Manoj K Gottipati1,2, Samuel A T Ellman3, Devan L Puhl1, Zhen Guan2, Phillip G Popovich2, Edmund F Palermo3, Ryan J Gilbert1.
Abstract
17β-Estradiol (E2) confers neuroprotection in preclinical models of spinal cord injury when administered systemically. The goal of this study was to apply E2 locally to the injured spinal cord for a sustained duration using poly(pro-E2) film biomaterials. Following contusive spinal cord injury in adult male mice, poly(pro-E2) films were implanted subdurally and neuroprotection was assessed using immunohistochemistry 7 days after injury and implantation. In these studies, poly(pro-E2) films modestly improved neuroprotection without affecting the inflammatory response when compared to the injured controls. To increase the E2 dose released, bolus-releasing poly(pro-E2) films were fabricated by incorporating unbound E2 into the poly(pro-E2) films. However, compared to the injured controls, bolus-releasing poly(pro-E2) films did not significantly enhance neuroprotection or limit inflammation at either 7 or 21 days post-injury. Future work will focus on developing poly(pro-E2) biomaterials capable of more precisely releasing therapeutic doses of E2.Entities:
Keywords: Estrogen; inflammation; neuroprotection; poly(prodrug); spinal cord injury
Mesh:
Substances:
Year: 2021 PMID: 33635633 PMCID: PMC8785687 DOI: 10.1021/acschemneuro.0c00798
Source DB: PubMed Journal: ACS Chem Neurosci ISSN: 1948-7193 Impact factor: 4.418